CliffBio

Sarfez Pharmaceuticals

Patent cliffs & loss of exclusivity

Extended release formulation technology; Reformulating existing drugs

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/sarfez-pharmaceuticals
Facebook URLhttps://www.facebook.com/Soaanz-107960954098419/
LinkedIn URLhttps://www.linkedin.com/company/sarfez-pharmaceutical-inc
Twitter URLhttps://twitter.com/sarfezpharma
Official Websitehttps://sarfezpharma.com

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. SOAANZTORSEMIDESmall mol.Oct 2033
  2. SOAANZTORSEMIDESmall mol.Oct 2033
  3. SOAANZTORSEMIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Sarfez Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio